Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EPS (Weighted Average and Diluted) (2020 - 2025)

iSpecimen (ISPC) has 6 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.42 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 72.19% year-over-year to -$0.42; the TTM value through Sep 2025 reached -$7.82, up 74.39%, while the annual FY2024 figure was -$17.58, 28.39% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.42 in Q3 2025 per ISPC's latest filing, down from -$0.41 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $3.23 in Q4 2021 and bottomed at -$19.23 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$2.47, with a median of -$0.42 recorded in 2025.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 423.62% in 2021, then plummeted 7912.5% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $3.23 in 2021, then tumbled by 107.43% to -$0.24 in 2022, then tumbled by 7912.5% to -$19.23 in 2023, then soared by 67.34% to -$6.28 in 2024, then soared by 93.31% to -$0.42 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.42 in Q3 2025, -$0.41 in Q2 2025, and -$0.71 in Q1 2025.